2C5-29967-61906
2 vaccinations
1 coded response
20 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 338 / FL
- Registered
- 2022-07-09
- Relationship
- Child or adolescent in my care
- Guardian
- 2MF-59347-12866
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-07-07
Dose 1 — Moderna
-
2022-07-09
Registered in v-safe
- 2022-07-09
- 2022-07-10
- 2022-07-11
- 2022-07-12
- 2022-07-13
- 2022-07-14
- 2022-07-21
- 2022-07-28
- 2022-08-04
- 2022-08-11
-
2022-08-15
Dose 2 — Moderna
- 2022-08-18
- 2022-08-19
- 2022-08-20
- 2022-08-22
- 2022-08-31
- 2022-09-05
- 2022-09-12
- 2022-09-20
-
2022-09-28
Survey response — day 42, dose 2, under 3MedDRA: Cough, Pyrexia, Rhinorrhoea — Feeling: Fair · Be unable to work or attend schoolFree text: Cough and runny nose and feverMedDRA releases: 2024-11 · check-in free text available
- 2022-11-14
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-07-07 | Moderna | No |
| 2 | 2022-08-15 | Moderna | No |
Free text
Release 12 (Under 3) — day 42, dose 2, under 3
Symptoms: Cough and runny nose and fever
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release